Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors

Figures & data

Figure 1. Head-to-head comparison of ¹¹¹In-DTPA-octreotide (¹¹¹In-DTPAOC) and ⁶⁴Cu-DOTATATE. Please note the additional foci in liver and carcinomatosis only seen on the ⁶⁴Cu-DOTATATE scan.

Figure 2. CT scan of a patient with a non-functioning pancreatic NET before and 6 months after treatment with four cycles of ¹⁷⁷Lu-DOTATATE. The size of the liver is reduced and almost all metastases have disappeared.